# Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

> **NCT06137664** · PHASE1,PHASE2 · RECRUITING · sponsor: **PATH** · enrollment: 2400 (estimated)

## Conditions studied

- Poliomyelitis

## Interventions

- **BIOLOGICAL:** Novel oral poliomyelitis vaccine type 1 (nOPV1)
- **BIOLOGICAL:** Novel oral poliomyelitis vaccine type 2 (nOPV2)
- **BIOLOGICAL:** Novel oral poliomyelitis vaccine type 3 (nOPV3)
- **BIOLOGICAL:** Bivalent Oral Poliomyelitis Vaccine (bOPV)

## Key facts

- **NCT ID:** NCT06137664
- **Lead sponsor:** PATH
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2027-12-15
- **Final completion:** 2027-12-15
- **Target enrollment:** 2400 (ESTIMATED)
- **Last updated:** 2025-06-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06137664

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06137664, "Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06137664. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*